InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
5 Jan 2026
Director
Buy indirect
7,111
$3.50
$24.89K
Ra Capital Management, L.p.
12 Dec 2025
Director
Buy indirect
101,462
$2.86
$290.18K
Ra Capital Management, L.p.
11 Dec 2025
Director
Buy indirect
213,099
$2.18
$464.56K
Ra Capital Management, L.p.
27 Jun 2024
Director
Buy indirect
1,059,375
$3.84
$4.07M
Ra Capital Management, L.p.
27 Jun 2024
Director
Buy indirect
11,949,171
$3.84
$45.88M
Ai Eti LLC
12 Aug 2021
10% owner
Buy
800,000
$12.50
$10.00M
Ra Capital Management, L.p.
12 Aug 2021
Director
Buy indirect
195,218
$12.50
$2.44M
Ra Capital Management, L.p.
12 Aug 2021
Director
Buy indirect
3,004,782
$12.50
$37.56M
Show all 45 transactions →

What was left out

Form 4 filings counted 96
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,676,580
History held since 11 Aug 2021